Recombinant Human GPC Protein，His

GPC (glypican) is a family of heparan sulfate proteoglycans that play pivotal roles in various cellular processes, including growth, differentiation, and regulation of cell signaling pathways. Research into GPC has gained momentum due to its involvement in pivotal biological functions and pathological conditions, such as cancer progression and development. GPCs are characterized by their attachment to the cell membrane via a glycosylphosphatidylinositol (GPI) anchor, allowing them to interact with a range of ligands and modulate signaling pathways, such as those involving fibroblast growth factors (FGFs) and Wnt proteins. The role of GPCs in cancer biology is particularly notable, as they are often found to be upregulated in various tumor types, contributing to tumor growth, metastasis, and resistance to therapy. Thus, GPCs serve not only as potential biomarkers for cancer diagnosis and prognosis but also as promising therapeutic targets. Advances in recombinant protein technology have enabled the production and characterization of GPC proteins, facilitating deeper insights into their structure-function relationships and biological activities. Understanding the intricate mechanisms by which GPCs influence cellular processes is crucial for developing novel therapeutic strategies and improving patient outcomes in cancer treatment. As research continues to uncover the complexities of GPC interactions within the tumor microenvironment, the potential for innovative therapeutic interventions targeting GPCs is becoming increasingly viable. Overall, GPCs represent an exciting area of study in the realm of cell biology and oncology, with significant implications for both basic research and clinical applications.